Cite
PND29 - Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting.
MLA
Väätäinen, S., et al. “PND29 - Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting.” Value in Health, vol. 20, no. 9, Oct. 2017, p. A722. EBSCOhost, https://doi.org/10.1016/j.jval.2017.08.1943.
APA
Väätäinen, S., Soini, E., Peltola, J., Charokopou, M., Taiha, M., & Kälviäinen, R. (2017). PND29 - Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting. Value in Health, 20(9), A722. https://doi.org/10.1016/j.jval.2017.08.1943
Chicago
Väätäinen, S, E Soini, J Peltola, M Charokopou, M Taiha, and R Kälviäinen. 2017. “PND29 - Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting.” Value in Health 20 (9): A722. doi:10.1016/j.jval.2017.08.1943.